Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1862, Issue 9, 2017, Pages 869-882

  Lin, Yi ^a   Ding, Dongxiao ^a,c   Huang, Qiansheng ^a   Liu, Qiong ^b   Lu, Haoyang ^b   Lu, Yanyang ^a,c   Chi, Yulang ^a,c   Sun, Xia ^a   Ye, Guozhu ^a   Zhu, Huimin ^a   Wei, Jie ^b   Dong, Sijun ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b XIAMEN UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Bisphenol A (BPA); Lipid accumulation; MicroRNA 192 (miR 192); Nonalcoholic fatty liver disease (NAFLD); Steatosis; Sterol regulatory element binding protein 1 (SREBF1)

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; LENTIVIRUS VECTOR; LIPID; MICRORNA 192; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; BENZHYDRYL DERIVATIVE; MICRORNA; PHENOL DERIVATIVE;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID HOMEOSTASIS; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIVER CELL; MALE; MOLECULAR PATHOLOGY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FATTY LIVER; GENETICS; LIPID METABOLISM; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BENZHYDRYL COMPOUNDS; CELL LINE, TUMOR; DOWN-REGULATION; FATTY LIVER; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIPIDS; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHENOLS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UP-REGULATION;

EID: 85020194449     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2017.05.001     Document Type: Article

References (60)

1. Huang, Y.Q., Wong, C.K., Zheng, J.S., Bouwman, H., Barra, R., Wahlstrom, B., Neretin, L., Wong, M.H., Bisphenol A (BPA) in China: a review of sources, environmental levels, and potential human health impacts. Environ. Int. 42 (2012), 91–99.
2. Walsh, B., The perils of plastic. Time 175 (2010), 44–46 (48, 50, passim).
3. Stahlhut, R.W., Welshons, W.V., Swan, S.H., Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 117 (2009), 784–789.
4. Izzotti, A., Kanitz, S., D'Agostini, F., Camoirano, A., De Flora, S., Formation of adducts by bisphenol A, an endocrine disruptor, in DNA in vitro and in liver and mammary tissue of mice. Mutat. Res. 679 (2009), 28–32.
5. Boucher, J.G., Boudreau, A., Ahmed, S., Atlas, E., In vitro effects of bisphenol A beta-D-glucuronide (BPA-G) on adipogenesis in human and murine preadipocytes. Environ. Health Perspect. 123 (2015), 1287–1293.
6. Rezg, R., El-Fazaa, S., Gharbi, N., Mornagui, B., Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ. Int. 64 (2014), 83–90.
7. Marmugi, A., Ducheix, S., Lasserre, F., Polizzi, A., Paris, A., Priymenko, N., Bertrand-Michel, J., Pineau, T., Guillou, H., Martin, P.G., Mselli-Lakhal, L., Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 55 (2012), 395–407.
8. Marmugi, A., Lasserre, F., Beuzelin, D., Ducheix, S., Huc, L., Polizzi, A., Chetivaux, M., Pineau, T., Martin, P., Guillou, H., Mselli-Lakhal, L., Adverse effects of long-term exposure to bisphenol A during adulthood leading to hyperglycaemia and hypercholesterolemia in mice. Toxicology 325 (2014), 133–143.
9. Jiang, Y., Xia, W., Zhu, Y., Li, X., Wang, D., Liu, J., Chang, H., Li, G., Xu, B., Chen, X., Li, Y., Xu, S., Mitochondrial dysfunction in early life resulted from perinatal bisphenol A exposure contributes to hepatic steatosis in rat offspring. Toxicol. Lett. 228 (2014), 85–92.
10. Huc, L., Lemarie, A., Gueraud, F., Helies-Toussaint, C., Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells. Toxicol. in Vitro 26 (2012), 709–717.
11. Wei, J., Sun, X., Chen, Y., Li, Y., Song, L., Zhou, Z., Xu, B., Lin, Y., Xu, S., Perinatal exposure to bisphenol A exacerbates nonalcoholic steatohepatitis-like phenotype in male rat offspring fed on a high-fat diet. J. Endocrinol. 222 (2014), 313–325.
12. Horton, J.D., Goldstein, J.L., Brown, M.S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002), 1125–1131.
13. Vrijens, K., Bollati, V., Nawrot, T.S., MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ. Health Perspect. 123 (2015), 399–411.
14. Izzotti, A., Pulliero, A., The effects of environmental chemical carcinogens on the microRNA machinery. Int. J. Hyg. Environ. Health 217 (2014), 601–627.
15. De Felice, B., Manfellotto, F., Palumbo, A., Troisi, J., Zullo, F., Di Carlo, C., Di Spiezio Sardo, A., De Stefano, N., Ferbo, U., Guida, M., Guida, M., Genome-wide microRNA expression profiling in placentas from pregnant women exposed to BPA. BMC Med. Genet., 8, 2015, 56.
16. Tilghman, S.L., Bratton, M.R., Segar, H.C., Martin, E.C., Rhodes, L.V., Li, M., McLachlan, J.A., Wiese, T.E., Nephew, K.P., Burow, M.E., Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One, 7, 2012, e32754.
17. Veiga-Lopez, A., Luense, L.J., Christenson, L.K., Padmanabhan, V., Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression. Endocrinology 154 (2013), 1873–1884.
18. Lynn, F.C., Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol. Metab. 20 (2009), 452–459.
19. Rottiers, V., Naar, A.M., MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13 (2012), 239–250.
20. Gomez-Lechon, M.J., Donato, M.T., Martinez-Romero, A., Jimenez, N., Castell, J.V., O'Connor, J.E., A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact. 165 (2007), 106–116.
21. Folch, J., Lees, M., Sloane Stanley, G.H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226 (1957), 497–509.
22. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M.W., Shipley, G.L., Vandesompele, J., Wittwer, C.T., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55 (2009), 611–622.
23. Xia, W., Jiang, Y., Li, Y., Wan, Y., Liu, J., Ma, Y., Mao, Z., Chang, H., Li, G., Xu, B., Chen, X., Xu, S., Early-life exposure to bisphenol a induces liver injury in rats involvement of mitochondria-mediated apoptosis. PLoS One, 9, 2014, e90443.
24. Ke, Z.H., Pan, J.X., Jin, L.Y., Xu, H.Y., Yu, T.T., Ullah, K., Rahman, T.U., Ren, J., Cheng, Y., Dong, X.Y., Sheng, J.Z., Huang, H.F., Bisphenol A exposure may induce hepatic lipid accumulation via reprogramming the DNA methylation patterns of genes involved in lipid metabolism. Sci. Rep., 6, 2016, 31331.
25. Strakovsky, R.S., Wang, H., Engeseth, N.J., Flaws, J.A., Helferich, W.G., Pan, Y.X., Lezmi, S., Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis. Toxicol. Appl. Pharmacol. 284 (2015), 101–112.
26. Foretz, M., Guichard, C., Ferre, P., Foufelle, F., Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 12737–12742.
27. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J.D., Brown, M.S., Goldstein, J.L., Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 13656–13661.
28. Yellaturu, C.R., Deng, X., Cagen, L.M., Wilcox, H.G., Mansbach, C.M. 2nd, Siddiqi, S.A., Park, E.A., Raghow, R., Elam, M.B., Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J. Biol. Chem. 284 (2009), 7518–7532.
29. Ono, H., Shimano, H., Katagiri, H., Yahagi, N., Sakoda, H., Onishi, Y., Anai, M., Ogihara, T., Fujishiro, M., Viana, A.Y., Fukushima, Y., Abe, M., Shojima, N., Kikuchi, M., Yamada, N., Oka, Y., Asano, T., Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52 (2003), 2905–2913.
30. Li, S., Brown, M.S., Goldstein, J.L., Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 3441–3446.
31. Bengoechea-Alonso, M.T., Ericsson, J., A phosphorylation cascade controls the degradation of active SREBP1. J. Biol. Chem. 284 (2009), 5885–5895.
32. Kim, K.H., Song, M.J., Yoo, E.J., Choe, S.S., Park, S.D., Kim, J.B., Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J. Biol. Chem. 279 (2004), 51999–52006.
33. Liu, W., Cao, H., Yan, J., Huang, R., Ying, H., ‘Micro-managers’ of hepatic lipid metabolism and NAFLD. Wiley Interdiscip. Rev. Syst. Biol. Med. 6 (2015), 581–593.
34. He, Z., Hu, C., Jia, W., miRNAs in non-alcoholic fatty liver disease. Front. Med. 10 (2016), 389–396.
35. Barad, O., Meiri, E., Avniel, A., Aharonov, R., Barzilai, A., Bentwich, I., Einav, U., Gilad, S., Hurban, P., Karov, Y., Lobenhofer, E.K., Sharon, E., Shiboleth, Y.M., Shtutman, M., Bentwich, Z., Einat, P., MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res. 14 (2004), 2486–2494.
36. Nagano, T., Higashisaka, K., Kunieda, A., Iwahara, Y., Tanaka, K., Nagano, K., Abe, Y., Kamada, H., Tsunoda, S., Nabeshi, H., Yoshikawa, T., Yoshioka, Y., Tsutsumi, Y., Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage. Nanotechnology, 24, 2013, 405102.
37. Becker, P.P., Rau, M., Schmitt, J., Malsch, C., Hammer, C., Bantel, H., Mullhaupt, B., Geier, A., Performance of serum microRNAs-122, − 192 and − 21 as biomarkers in patients with non-alcoholic steatohepatitis. PLoS One, 10, 2015, e0142661.
38. Horie, T., Nishino, T., Baba, O., Kuwabara, Y., Nakao, T., Nishiga, M., Usami, S., Izuhara, M., Sowa, N., Yahagi, N., Shimano, H., Matsumura, S., Inoue, K., Marusawa, H., Nakamura, T., Hasegawa, K., Kume, N., Yokode, M., Kita, T., Kimura, T., Ono, K., MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat. Commun., 4, 2013, 2883.
39. Tsai, W.C., Hsu, S.D., Hsu, C.S., Lai, T.C., Chen, S.J., Shen, R., Huang, Y., Chen, H.C., Lee, C.H., Tsai, T.F., Hsu, M.T., Wu, J.C., Huang, H.D., Shiao, M.S., Hsiao, M., Tsou, A.P., MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122 (2012), 2884–2897.
40. Gao, L.L., Li, M., Wang, Q., Liu, S.A., Zhang, J.Q., Cheng, J., HCBP6 modulates triglyceride homeostasis in hepatocytes via the SREBP1c/FASN pathway. J. Cell. Biochem. 116 (2015), 2375–2384.
41. Iliopoulos, D., Drosatos, K., Hiyama, Y., Goldberg, I.J., Zannis, V.I., MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J. Lipid Res. 51 (2010), 1513–1523.
42. Xu, Y., Zalzala, M., Xu, J., Li, Y., Yin, L., Zhang, Y., A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism. Nat. Commun., 6, 2015, 7466.
43. Shan, W., Gao, L., Zeng, W., Hu, Y., Wang, G., Li, M., Zhou, J., Ma, X., Tian, X., Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death Dis., 6, 2015, e1833.
44. Ng, R., Wu, H., Xiao, H., Chen, X., Willenbring, H., Steer, C.J., Song, G., Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia. Hepatology 60 (2014), 554–564.
45. Shirasaki, T., Honda, M., Shimakami, T., Horii, R., Yamashita, T., Sakai, Y., Sakai, A., Okada, H., Watanabe, R., Murakami, S., Yi, M., Lemon, S.M., Kaneko, S., MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J. Virol. 87 (2013), 5270–5286.
46. Singaravelu, R., Chen, R., Lyn, R.K., Jones, D.M., O'Hara, S., Rouleau, Y., Cheng, J., Srinivasan, P., Nasheri, N., Russell, R.S., Tyrrell, D.L., Pezacki, J.P., Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis. Hepatology 59 (2014), 98–108.
47. Tan, Y., Ge, G., Pan, T., Wen, D., Gan, J., A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS One, 9, 2014, e105192.
48. Pogribny, I.P., Starlard-Davenport, A., Tryndyak, V.P., Han, T., Ross, S.A., Rusyn, I., Beland, F.A., Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab. Investig. 90 (2010), 1437–1446.
49. Gil-Zamorano, J., Martin, R., Daimiel, L., Richardson, K., Giordano, E., Nicod, N., Garcia-Carrasco, B., Soares, S.M., Iglesias-Gutierrez, E., Lasuncion, M.A., Sala-Vila, A., Ros, E., Ordovas, J.M., Visioli, F., Davalos, A., Docosahexaenoic acid modulates the enterocyte Caco-2 cell expression of microRNAs involved in lipid metabolism. J. Nutr. Elder. 144 (2014), 575–585.
50. Takamura, T., Misu, H., Ota, T., Kaneko, S., Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocr. J. 59 (2012), 745–763.
51. Farese, R.V. Jr., Zechner, R., Newgard, C.B., Walther, T.C., The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 15 (2012), 570–573.
52. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., Kim, V.N., The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003), 415–419.
53. Tijsterman, M., Plasterk, R.H., Dicers at RISC; the mechanism of RNAi. Cell 117 (2004), 1–3.
54. Lanford, R.E., Hildebrandt-Eriksen, E.S., Petri, A., Persson, R., Lindow, M., Munk, M.E., Kauppinen, S., Orum, H., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327 (2010), 198–201.
55. Montgomery, R.L., Hullinger, T.G., Semus, H.M., Dickinson, B.A., Seto, A.G., Lynch, J.M., Stack, C., Latimer, P.A., Olson, E.N., van Rooij, E., Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124 (2011), 1537–1547.
56. Janssen, H.L., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A.J., Patick, A.K., Chen, A., Zhou, Y., Persson, R., King, B.D., Kauppinen, S., Levin, A.A., Hodges, M.R., Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368 (2013), 1685–1694.
57. Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L.E., Galas, D.J., Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 4402–4407.
58. Baker, L.A., Lee, K.C., Palacios Jimenez, C., Alibhai, H., Chang, Y.M., Leckie, P.J., Mookerjee, R.P., Davies, N.A., Andreola, F., Jalan, R., Circulating microRNAs reveal time course of organ injury in a porcine model of acetaminophen-induced acute liver failure. PLoS One, 10, 2015, e0128076.
59. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., Castoldi, M., Soutschek, J., Koteliansky, V., Rosenwald, A., Basson, M.A., Licht, J.D., Pena, J.T., Rouhanifard, S.H., Muckenthaler, M.U., Tuschl, T., Martin, G.R., Bauersachs, J., Engelhardt, S., MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456 (2008), 980–984.
60. Patrick, D.M., Montgomery, R.L., Qi, X., Obad, S., Kauppinen, S., Hill, J.A., van Rooij, E., Olson, E.N., Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120 (2010), 3912–3916.